期刊论文

中文

中国中医药信息杂志

1005-5304

2018

25

2

42-46

10.3969/j.issn.1005-5304.2018.02.010

国家自然科学基金（81373602） 湖南省自然科学基金青年基金（2017JJ3186） 湖南省中医药研究院重点课题（201504）

本校为第一机构

目的观察健脾消癌方对转化生长因子-β1(TGF-β1)诱导的SW620细胞上皮间质转化的影响,探讨其防治结直肠癌的可能机制。方法体外培养结直肠癌细胞SW620。CCK-8法和Transwell小室实验测定细胞增殖、侵袭及迁移能力,qRT-PCR和Western blot检测E-cadherin和Vimentin的基因和蛋白表达。结果健脾消癌方药物血清能抑制SW620细胞体外增殖、迁移和侵袭能力;与空白组比较,TGF-β1诱导组细胞E-cadherin表达水平下降,Vimentin表达水平升高(P

Objective To observe the effects of Jianpi Xiaoai Prescription on epithelial-mesenchymal transition of colorectal cancer cell SW620 induced by TGF-β1; To discuss its possible mechanism of action for prevention and treatment of colorectal cancer. Methods Colorectal cancer cells SW620 were cultured in vitro. By conducting CCK-8 and Transwell experiments, the proliferation, invasion and migration of colorectal cancer cell (SW620) were detected. qRT-PCR and Western blot experiments were applied to verify the mRNA and protein expression level of E-...